Alpha Core Capital LLC Merck & Co., Inc. Transaction History
Alpha Core Capital LLC
- $2.55 Billion
- Q2 2025
A detailed history of Alpha Core Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Alpha Core Capital LLC holds 35,203 shares of MRK stock, worth $2.95 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
35,203
Previous 27,141
29.7%
Holding current value
$2.95 Million
Previous $2.44 Million
14.37%
% of portfolio
0.11%
Previous 0.22%
Shares
16 transactions
Others Institutions Holding MRK
# of Institutions
3,849Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.94 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.45 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.95 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $213B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...